Xu et al. [86] in 2013 included 17 case–control studies on XRCC3 T241M, their meta-analysis all available data did not support any appreciable association between the XRCC3 Thr241Met polymorphism and lung cancer risk in any populations. Here, XRCC3 is linked to lung carcinoma.